Index -
P/E -
EPS (ttm) -0.52
Insider Own 29.52%
Shs Outstand 181.22M
Perf Week 1.14%
Market Cap 378.39M
Forward P/E -
EPS next Y -0.35
Insider Trans 3.08%
Shs Float 149.83M
Perf Month 0.00%
Income -108.96M
PEG -
EPS next Q -0.08
Inst Own 28.24%
Short Float 8.69%
Perf Quarter 57.52%
Sales 71.08M
P/S 5.32
EPS this Y 49.74%
Inst Trans -13.42%
Short Ratio 6.35
Perf Half Y 93.00%
Book/sh 0.91
P/B 1.95
EPS next Y -6.12%
ROA -34.17%
Short Interest 13.02M
Perf Year 110.18%
Cash/sh 0.48
P/C 3.70
EPS next 5Y -
ROE -46.17%
52W Range 0.67 - 2.20
Perf YTD 64.81%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -50.46%
52W High -19.09%
Beta 2.18
Dividend TTM -
Quick Ratio 3.09
Sales past 5Y 14.12%
Gross Margin 27.73%
52W Low 164.06%
ATR (14) 0.14
Dividend Ex-Date -
Current Ratio 5.01
EPS Y/Y TTM 29.89%
Oper. Margin -151.41%
RSI (14) 51.75
Volatility 7.79% 7.37%
Employees 225
Debt/Eq 0.12
Sales Y/Y TTM -2.05%
Profit Margin -153.29%
Recom 1.00
Target Price 3.25
Option/Short Yes / Yes
LT Debt/Eq 0.11
EPS Q/Q 46.96%
Payout -
Rel Volume 0.95
Prev Close 1.84
Sales Surprise 9.75%
EPS Surprise 25.80%
Sales Q/Q 16.23%
Earnings Nov 01 BMO
Avg Volume 2.05M
Price 1.78
SMA20 -0.67%
SMA50 7.39%
SMA200 52.40%
Trades
Volume 1,939,047
Change -3.26%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-10-24 Initiated
Lake Street
Buy
$3
Mar-29-23 Initiated
UBS
Neutral
$2.25
Nov-29-22 Initiated
Oppenheimer
Outperform
$4.50
Oct-04-22 Initiated
B. Riley Securities
Buy
$9.50
Dec-17-21 Initiated
UBS
Neutral
$7
Jun-21-21 Initiated
Cowen
Outperform
$20
Oct-28-24 08:00AM
Oct-18-24 08:05AM
Oct-08-24 11:11AM
Sep-17-24 08:00AM
Sep-09-24 10:07AM
10:08AM
Loading…
Sep-04-24 10:08AM
08:30AM
Sep-03-24 04:30PM
08:30AM
Aug-28-24 04:30PM
Aug-20-24 09:00AM
Aug-01-24 04:05PM
(Business Wire) -8.18%
+11.88%
Jul-18-24 08:05AM
Jun-27-24 09:00AM
Jun-24-24 07:00AM
08:30AM
Loading…
May-28-24 08:30AM
May-16-24 02:13PM
May-15-24 08:30AM
May-02-24 10:43AM
May-01-24 08:56PM
04:05PM
Apr-23-24 08:00AM
Apr-17-24 08:00AM
Apr-15-24 08:30AM
Mar-27-24 09:00AM
Mar-20-24 08:00AM
Mar-19-24 08:30AM
Mar-15-24 05:35PM
Mar-06-24 08:30AM
Mar-05-24 09:40AM
11:36AM
Loading…
Feb-29-24 11:36AM
Feb-28-24 04:05PM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-15-24 04:15PM
(Business Wire) +10.78%
-6.19%
Feb-13-24 08:30AM
Jan-11-24 04:56PM
Jan-08-24 08:05AM
Jan-05-24 08:30AM
Dec-19-23 08:05AM
Dec-11-23 08:05AM
Nov-15-23 12:00PM
Nov-14-23 08:00AM
Nov-06-23 05:05PM
Nov-03-23 10:55AM
Nov-02-23 05:58PM
04:05PM
Oct-31-23 12:00PM
10:01AM
Oct-27-23 12:00PM
Oct-24-23 08:10AM
Oct-18-23 04:14PM
Oct-10-23 07:00AM
Oct-09-23 08:05AM
Oct-04-23 08:05AM
Sep-14-23 08:05AM
Sep-09-23 01:03AM
Aug-05-23 07:14AM
Aug-03-23 09:15AM
08:00AM
Aug-02-23 05:05PM
Jul-27-23 05:25PM
Jul-17-23 10:24AM
Jul-03-23 06:17AM
Jun-05-23 12:30PM
May-11-23 09:25AM
08:05AM
May-09-23 07:25PM
10:12AM
May-04-23 06:05PM
Apr-27-23 10:03AM
08:30AM
Apr-24-23 08:10AM
Apr-17-23 06:41AM
Apr-11-23 09:40AM
Apr-10-23 05:22PM
Apr-03-23 04:05PM
Mar-29-23 03:36PM
Mar-14-23 07:42AM
Mar-08-23 05:00PM
Mar-02-23 08:25AM
Mar-01-23 05:00PM
Feb-28-23 11:25AM
08:00AM
Feb-22-23 05:00PM
Feb-16-23 09:40AM
Feb-13-23 08:30AM
Jan-23-23 11:34AM
Dec-27-22 09:37AM
Dec-19-22 08:00AM
Dec-14-22 08:00AM
Dec-06-22 05:00PM
(Business Wire) -5.52%
-9.09%
Nov-18-22 06:20AM
Nov-09-22 05:40AM
Nov-06-22 07:31AM
Nov-05-22 05:39AM
Nov-03-22 08:00AM
Oct-24-22 08:00AM
Oct-20-22 02:41PM
Oct-07-22 05:33AM
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stoica Andrei G Chief Technology Officer Oct 01 '24 Sale 1.79 1,696 3,034 1,465,534 Oct 03 04:30 PM Stoica Andrei G Officer Oct 01 '24 Proposed Sale 1.79 1,696 3,034 Oct 01 03:28 PM Stoica Andrei G Chief Technology Officer Sep 24 '24 Sale 1.74 3,296 5,735 1,467,230 Sep 26 04:15 PM Stoica Andrei G Officer Sep 24 '24 Proposed Sale 1.74 3,296 5,734 Sep 24 03:10 PM Phanstiel S. Louise Director Sep 13 '24 Sale 1.96 60,049 117,792 0 Sep 13 04:15 PM S. Louise Phanstiel Director Sep 13 '24 Proposed Sale 1.93 60,049 115,895 Sep 13 04:06 PM Stoica Andrei G Chief Technology Officer Sep 05 '24 Sale 1.70 10,212 17,320 1,470,526 Sep 09 04:20 PM Stoica Andrei G Officer Sep 05 '24 Proposed Sale 1.70 10,212 17,321 Sep 05 03:37 PM ROBBINS LARRY Director Aug 30 '24 Buy 1.07 244,774 262,251 9,955,144 Sep 04 04:34 PM ROBBINS LARRY Director Aug 28 '24 Buy 0.98 1,246,950 1,221,382 9,280,451 Aug 30 04:18 PM ROBBINS LARRY Director Aug 29 '24 Buy 1.07 429,919 461,991 9,710,370 Aug 30 04:18 PM DEVIVO JOSEPH President & CEO Aug 07 '24 Buy 0.95 104,000 98,519 7,009,221 Aug 07 04:34 PM Stoica Andrei G Chief Technology Officer Jul 02 '24 Sale 0.87 1,703 1,487 1,480,738 Jul 05 04:00 PM Stoica Andrei G Chief Technology Officer Jun 25 '24 Sale 0.92 3,363 3,107 1,482,441 Jun 27 04:00 PM Stoica Andrei G Chief Technology Officer Jun 05 '24 Sale 0.90 11,754 10,602 1,485,804 Jun 07 05:50 PM Getz Heather C EVP, CFO & COO May 03 '24 Sale 0.95 59,848 57,035 2,699,469 May 07 04:15 PM Stoica Andrei G Chief Technology Officer Apr 02 '24 Sale 1.00 1,778 1,782 1,497,558 Apr 04 04:30 PM Stoica Andrei G Chief Technology Officer Mar 25 '24 Sale 1.02 3,298 3,380 1,499,336 Mar 27 04:15 PM Stoica Andrei G Chief Technology Officer Mar 11 '24 Sale 1.14 76,498 87,208 889,675 Mar 13 04:31 PM Getz Heather C EVP, CFO & COO Mar 11 '24 Sale 1.14 81,448 92,851 1,435,788 Mar 13 04:30 PM Stoica Andrei G Chief Technology Officer Mar 05 '24 Sale 1.15 12,113 13,930 966,173 Mar 07 04:15 PM Getz Heather C EVP, CFO & COO Jan 05 '24 Sale 1.02 66,142 67,465 1,517,236 Jan 09 04:13 PM Stoica Andrei G Chief Technology Officer Jan 05 '24 Sale 1.02 35,612 36,324 978,286 Jan 09 04:12 PM Stoica Andrei G Chief Technology Officer Dec 26 '23 Sale 1.03 2,247 2,326 1,013,898 Dec 28 04:00 PM Stoica Andrei G Chief Technology Officer Dec 05 '23 Sale 0.99 7,935 7,895 1,016,145 Dec 07 04:49 PM
Index S&P 500
P/E 27.60
EPS (ttm) 2.93
Insider Own 1.31%
Shs Outstand 241.71M
Perf Week -0.05%
Market Cap 18.78B
Forward P/E 18.66
EPS next Y 4.33
Insider Trans -3.64%
Shs Float 229.23M
Perf Month 1.38%
Income 701.50M
PEG 2.76
EPS next Q 1.01
Inst Own 98.55%
Short Float 2.53%
Perf Quarter -3.31%
Sales 3.99B
P/S 4.71
EPS this Y 3.13%
Inst Trans 0.65%
Short Ratio 4.00
Perf Half Y 6.53%
Book/sh 21.33
P/B 3.79
EPS next Y 6.11%
ROA 7.70%
Short Interest 5.81M
Perf Year 22.22%
Cash/sh 10.50
P/C 7.70
EPS next 5Y 10.00%
ROE 13.85%
52W Range 65.55 - 84.67
Perf YTD 13.18%
Dividend Est. -
P/FCF 18.33
EPS past 5Y -
ROI 9.39%
52W High -4.49%
Beta 0.99
Dividend TTM -
Quick Ratio 3.32
Sales past 5Y 7.63%
Gross Margin 54.65%
52W Low 23.37%
ATR (14) 1.22
Dividend Ex-Date -
Current Ratio 3.99
EPS Y/Y TTM 51.38%
Oper. Margin 23.14%
RSI (14) 49.84
Volatility 1.50% 1.41%
Employees 6990
Debt/Eq 0.52
Sales Y/Y TTM -1.26%
Profit Margin 17.59%
Recom 2.18
Target Price 88.47
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 601.52%
Payout 0.00%
Rel Volume 1.06
Prev Close 81.15
Sales Surprise 0.96%
EPS Surprise 4.19%
Sales Q/Q 2.74%
Earnings Nov 04 AMC
Avg Volume 1.45M
Price 80.87
SMA20 0.05%
SMA50 -0.06%
SMA200 4.76%
Trades
Volume 1,544,374
Change -0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-01-24 Downgrade
Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Jun-30-20 Upgrade
Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$62
Show Previous Ratings
Oct-30-24 09:15AM
Oct-28-24 05:45PM
10:01AM
06:18AM
Oct-25-24 02:57PM
09:00AM
Loading…
Oct-23-24 09:00AM
06:00AM
Oct-21-24 05:45PM
Oct-15-24 05:45PM
08:05AM
07:32AM
07:02AM
Oct-14-24 02:07PM
08:05AM
Oct-11-24 09:00AM
12:10PM
Loading…
Oct-09-24 12:10PM
Oct-08-24 05:45PM
Oct-04-24 08:22AM
Oct-02-24 05:45PM
Oct-01-24 09:36AM
Sep-30-24 09:17AM
09:00AM
Sep-26-24 05:45PM
Sep-24-24 09:40AM
Sep-20-24 05:45PM
Sep-17-24 09:00AM
Sep-11-24 09:50AM
Sep-06-24 09:00AM
Sep-02-24 09:40AM
Aug-29-24 08:08AM
11:30AM
Loading…
Aug-28-24 11:30AM
Aug-26-24 09:00AM
Aug-20-24 08:01AM
Aug-13-24 09:00AM
Aug-09-24 08:20AM
06:51AM
Aug-05-24 09:15AM
Aug-02-24 09:00AM
Aug-01-24 04:40PM
Jul-31-24 09:30AM
Jul-30-24 01:04PM
11:20AM
(Thomson Reuters StreetEvents)
08:22AM
08:08AM
04:32AM
Jul-29-24 07:22PM
05:30PM
05:15PM
04:10PM
(Associated Press Finance)
04:01PM
Jul-26-24 11:52AM
05:12AM
Jul-25-24 09:15AM
08:19AM
Jul-22-24 05:45PM
Jul-19-24 08:55AM
Jul-17-24 09:10AM
Jul-16-24 05:45PM
09:00AM
Jul-09-24 04:05AM
Jul-08-24 05:45PM
Jul-04-24 08:35AM
Jul-02-24 08:22AM
Jun-27-24 10:25AM
Jun-25-24 05:45PM
09:30AM
Jun-24-24 09:00AM
Jun-11-24 09:00AM
Jun-04-24 12:08PM
May-31-24 09:00AM
May-29-24 09:30AM
May-23-24 08:53AM
06:00AM
May-21-24 08:08AM
May-20-24 09:00AM
May-13-24 09:30AM
May-09-24 08:21AM
May-07-24 11:12AM
09:00AM
May-04-24 01:07AM
May-03-24 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM
07:17AM
(Thomson Reuters StreetEvents)
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
04:40PM
04:07PM
(Associated Press Finance)
04:01PM
Apr-30-24 06:27AM
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM
Index NDX, S&P 500
P/E 23.95
EPS (ttm) 3.65
Insider Own 3.16%
Shs Outstand 455.34M
Perf Week -1.74%
Market Cap 39.89B
Forward P/E 18.58
EPS next Y 4.70
Insider Trans -0.76%
Shs Float 442.22M
Perf Month -4.05%
Income 1.68B
PEG 2.21
EPS next Q 1.26
Inst Own 76.57%
Short Float 2.06%
Perf Quarter 4.69%
Sales 19.56B
P/S 2.04
EPS this Y 9.07%
Inst Trans 1.45%
Short Ratio 3.25
Perf Half Y 12.23%
Book/sh 18.20
P/B 4.80
EPS next Y 9.67%
ROA 5.06%
Short Interest 9.12M
Perf Year 31.22%
Cash/sh 7.81
P/C 11.18
EPS next 5Y 10.83%
ROE 21.70%
52W Range 65.77 - 94.55
Perf YTD 12.97%
Dividend Est. 0.12 (0.14%)
P/FCF 23.48
EPS past 5Y -2.54%
ROI 9.50%
52W High -7.62%
Beta 1.41
Dividend TTM 0.12 (0.14%)
Quick Ratio 0.98
Sales past 5Y 4.14%
Gross Margin 43.87%
52W Low 32.81%
ATR (14) 2.01
Dividend Ex-Date Oct 18, 2024
Current Ratio 1.23
EPS Y/Y TTM 8.62%
Oper. Margin 14.39%
RSI (14) 43.28
Volatility 2.70% 1.83%
Employees 51000
Debt/Eq 1.24
Sales Y/Y TTM 1.42%
Profit Margin 8.56%
Recom 1.90
Target Price 96.06
Option/Short Yes / Yes
LT Debt/Eq 1.12
EPS Q/Q 24.57%
Payout 3.97%
Rel Volume 1.15
Prev Close 87.20
Sales Surprise -0.11%
EPS Surprise 8.31%
Sales Q/Q 0.85%
Earnings Oct 30 BMO
Avg Volume 2.80M
Price 87.35
SMA20 -2.42%
SMA50 -1.37%
SMA200 3.91%
Trades
Volume 3,210,102
Change 0.17%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-26-24 Downgrade
UBS
Neutral → Sell
$84 → $74
Sep-18-24 Upgrade
BTIG Research
Neutral → Buy
$100
Sep-09-24 Initiated
JP Morgan
Neutral
$90
Aug-06-24 Initiated
Stifel
Buy
$100
May-30-24 Initiated
Goldman
Neutral
$87
Feb-15-24 Initiated
HSBC Securities
Buy
$100
Feb-12-24 Upgrade
UBS
Sell → Neutral
$66 → $88
Nov-30-23 Initiated
Jefferies
Hold
$80
Nov-27-23 Downgrade
UBS
Neutral → Sell
$86 → $66
Sep-19-23 Initiated
Citigroup
Buy
$82
Aug-25-23 Initiated
Argus
Buy
$80
Aug-16-23 Initiated
Wells Fargo
Overweight
$90
Jul-31-23 Initiated
BofA Securities
Neutral
$82
Jun-27-23 Initiated
Morgan Stanley
Equal-Weight
$76
May-16-23 Initiated
Oppenheimer
Outperform
$97
Apr-26-23 Initiated
UBS
Neutral
$86
Apr-19-23 Initiated
Piper Sandler
Overweight
$95
Apr-10-23 Initiated
BTIG Research
Neutral
Mar-13-23 Initiated
Evercore ISI
Outperform
$90
Feb-17-23 Initiated
Mizuho
Buy
$90
Show Previous Ratings
Today 06:57AM
02:58AM
Oct-30-24 06:20AM
Oct-24-24 12:16PM
Oct-21-24 12:10PM
12:10PM
Loading…
12:10PM
Oct-18-24 02:30PM
09:20AM
Oct-17-24 09:00AM
Oct-16-24 12:38PM
Oct-14-24 09:00AM
Oct-09-24 09:00AM
Oct-08-24 08:46AM
(Investor's Business Daily)
08:00AM
Oct-07-24 09:00AM
02:30AM
Loading…
02:30AM
Oct-06-24 01:24PM
Sep-30-24 10:35AM
(The Wall Street Journal)
Sep-27-24 04:32PM
Sep-26-24 09:00AM
Sep-24-24 06:40PM
09:00AM
Sep-19-24 09:00AM
Sep-18-24 04:50PM
Sep-12-24 09:40PM
05:02PM
Aug-26-24 09:00AM
Aug-21-24 09:00AM
Aug-20-24 08:30AM
Aug-19-24 10:00AM
09:50AM
Loading…
Aug-14-24 09:50AM
Aug-02-24 01:37PM
Jul-31-24 06:20AM
Jul-25-24 08:45AM
Jul-21-24 10:00AM
Jul-18-24 03:26AM
Jul-15-24 12:15PM
Jul-13-24 08:45PM
Jul-12-24 06:54AM
Jul-11-24 02:01PM
Jul-10-24 10:15AM
Jul-08-24 08:00AM
Jul-02-24 11:56AM
Jun-28-24 08:28PM
08:26PM
Jun-26-24 12:32PM
09:52AM
Jun-25-24 12:46PM
Jun-24-24 11:20AM
10:00AM
Jun-20-24 10:47AM
Jun-17-24 12:12PM
Jun-10-24 04:06PM
Jun-07-24 12:40PM
Jun-04-24 09:00AM
May-30-24 10:00AM
May-28-24 06:45AM
May-26-24 09:58PM
May-22-24 06:39PM
09:00AM
May-21-24 09:00AM
May-15-24 12:08PM
May-14-24 09:00AM
May-13-24 02:25PM
May-10-24 09:00AM
May-07-24 08:19AM
May-06-24 08:05AM
06:58AM
May-05-24 08:00AM
May-03-24 09:53AM
May-02-24 04:05PM
May-01-24 09:30AM
Apr-30-24 04:41PM
04:29PM
12:56PM
12:37PM
12:21PM
(The Wall Street Journal)
10:54AM
10:32AM
(The Wall Street Journal)
09:30AM
07:30AM
06:20AM
Apr-29-24 09:00AM
Apr-28-24 08:00AM
Apr-25-24 09:13PM
Apr-24-24 11:34AM
09:30AM
Apr-23-24 05:50PM
01:38PM
Apr-22-24 06:00PM
11:10AM
07:07AM
Apr-19-24 09:55AM
Apr-18-24 10:32AM
09:00AM
Apr-17-24 10:48AM
Apr-16-24 08:00AM
Apr-15-24 01:18PM
Apr-13-24 12:16PM
Apr-12-24 08:00AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Aug 14 '24 Sale 83.22 19,008 1,581,846 38,541 Aug 15 04:45 PM Kenneth Stacherski Officer Aug 14 '24 Proposed Sale 82.74 19,008 1,572,774 Aug 14 05:57 PM Jan Makela Officer Aug 12 '24 Proposed Sale 83.20 33,096 2,753,587 Aug 12 04:58 PM Westrick Thomas J. CEO, Patient Care Solutions Aug 07 '24 Sale 80.78 2,750 222,145 17,509 Aug 07 06:18 PM Thomas Westrick Officer Aug 07 '24 Proposed Sale 80.78 2,750 222,146 Aug 07 05:30 PM Kass-Hout Taha Chief Technology Officer May 28 '24 Sale 78.70 3,300 259,710 67,300 May 29 04:05 PM Makela Jan CEO, Imaging May 15 '24 Option Exercise 74.35 66,955 4,978,229 130,303 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Option Exercise 63.51 20,227 1,284,617 83,575 May 15 07:15 PM Makela Jan CEO, Imaging May 15 '24 Sale 81.54 66,955 5,459,511 63,348 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Sale 81.57 20,227 1,649,916 63,348 May 15 07:15 PM Jimenez Frank R GC & Corporate Secretary May 01 '24 Buy 76.52 1,315 100,624 75,796 May 02 06:00 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite